Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.
Yu G, Zhang Y, Yu S, Yin Z, Weng G, Xu N, Du X, Lin D, Xiao J, Sun Z, Zhang H, Liang X, Guo Z, Zhao W, Dai M, Fan Z, Xuan L, Liu H, Xu D, Ye J, Jiang X, Shi P, Jin H, Liu Q.
Yu G, et al. Among authors: jiang x.
Clin Cancer Res. 2025 Jan 6;31(1):87-97. doi: 10.1158/1078-0432.CCR-24-1332.
Clin Cancer Res. 2025.
PMID: 39531539